Filter Results :

Your search for Cancer Drug Market returned 93 reports

Sort by


Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics

31 Jan 2015  |  Published by:  GBI Research
Summary“Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics”, which provides in-depth analysis of the Colorectal Cancer (CRC) therapeutics market in the eight major geographies of the US, Canada, the ...

$ 4,995.00

Read More

Breast Cancer Diagnostic and Drug Technologies: Global Markets

01 Jan 2015  |  Published by:  BCC Research
The global market for breast cancer diagnostic and drug technologies was about $20.8 billion in 2012. This market reached about $22.3 billion in 2014 and is expected to reach $27 billion in 2019, registering a compound annual growth rate (CAGR) of 4% through 2014-2019. This report provides:...

$ 6,650.00

Read More

Breath Analyzers Market by Technology (Fuel Cell, Semiconductor, Infrared, Crystal), by Application (Alcohol, Drug Abuse, Tuberculosis, Asthma, Cancer), by End User (Law Enforcement, Enterprises, Individuals) - Analysis & Global Forecast to 2019

01 Jan 2015  |  Published by:  MarketsandMarkets
Report Description Breath analyzers are devices used to detect the presence of different compounds in the breath sample of individuals. They are most commonly used to measure blood alcohol content levels (BAC). These devices play a significant role in the conviction of DUI offenders. Growth...

$ 4,650.00

Read More

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2023

30 Nov 2014  |  Published by:  GlobalData
SummaryColorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus represents a huge burden on healthcare systems. This report focuses on the current treatment landscape, unmet needs, current pipeline, ...

$ 10,995.00

Read More

PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023

28 Nov 2014  |  Published by:  GlobalData
Summary PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - US Drug Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus repre...

$ 4,995.00

Read More

PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023

28 Nov 2014  |  Published by:  GlobalData
Summary PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - 5EU Drug Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus repr...

$ 6,995.00

Read More

PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023

28 Nov 2014  |  Published by:  GlobalData
Summary PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - Japan Drug Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus re...

$ 4,995.00

Read More

PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023

28 Nov 2014  |  Published by:  GlobalData
Summary PharmaPoint Country Evaluation report, “PharmaPoint: Colorectal Cancer - China Drug Forecast and Market Analysis to 2023”. Colorectal cancer (CRC) is the second leading cause of mortality among cancer patients in the world and is the third most diagnosed cancer globally, and thus re...

$ 4,995.00

Read More

Global Prostate Cancer Drugs Market 2014-2018

05 Nov 2014  |  Published by:  Technavio
Prostate cancer initiates in the prostate, which is an exocrine gland present in the male reproductive system. The main function of the prostate is to make fluid for semen. The risk of developing prostate cancer is age dependent. Prostate cancer affects mostly men over the age of 65 and rarely...

$ 2,500.00

Read More

PharmaPoint: HER2-Positive Breast Cancer - US Drug Forecast and Market Analysis to 2023

30 Sep 2014  |  Published by:  GlobalData
SummaryHER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage...

$ 4,995.00

Read More

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

30 Sep 2014  |  Published by:  GlobalData
SummaryHER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage...

$ 10,995.00

Read More

PharmaPoint: HER2-Positive Breast Cancer - 5EU Drug Forecast and Market Analysis to 2023

30 Sep 2014  |  Published by:  GlobalData
SummaryHER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage...

$ 6,995.00

Read More

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023

30 Sep 2014  |  Published by:  GlobalData
SummaryHER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage...

$ 4,995.00

Read More

PharmaPoint: HER2-Positive Breast Cancer - China Drug Forecast and Market Analysis to 2023

30 Sep 2014  |  Published by:  GlobalData
SummaryHER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. This report focuses on the current treatment landscape, unmet needs, current pipeline, and commercial opportunities in the HER2-positive breast cancer market, with coverage...

$ 4,995.00

Read More

Human Microbiome Market by Disease (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder), Application (Therapeutic, Diagnostic) & by Product (Probiotic, Prebiotic, Food, Medical Food, Supplement, Device, Drug) - Global Forecast to 2023

10 Sep 2014  |  Published by:  MarketsandMarkets
Report Description Need for early diagnosis and efficient treatment with microbiome therapy for maintaining healthy lifestyle will boost the human microbiome market. The product segment is expected to account for the largest share of the human microbiome market in the coming years. The hig...

$ 4,650.00

Read More
Total 93 records.